Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...
Comorbid chronic inflammatory diseases influence the prognosis of alopecia areata, according to study findings.
A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...
The goal is to find a cure for alopecia areata, an autoimmune disease that causes hair loss in distinct round patches.
Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles. Breakdown of immune privilege in hair follicles leads to ...
The risk for alopecia areata is increased among patients with lower serum levels of vitamin D and zinc, but no relationship was observed with copper.
Considering taking supplements to treat alopecia areata? Below is a list of common natural remedies used to treat or reduce the symptoms of alopecia areata. Follow the links to read common uses ...
Having asthma, Hashimoto’s thyroiditis or atopic dermatitis in addition to alopecia areata raised the odds for early-onset, severe and prolonged alopecia areata, according to a research letter ...
Alopecia areata (AA) is a common autoimmune disease that leads to sudden circular hair loss. The clinical course of AA is unpredictable and varies greatly from individual to individual.
A recent case-control study found a significant association in the prevalence of alopecia areata in patients diagnosed with celiac disease.
Their results have now been published in the journal "Allergy". Alopecia areata (AA) is a common autoimmune disease that leads to sudden circular hair loss. The clinical course of AA is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results